Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Hepatology

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.26350PMID 23463346PMCID PMC3695036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers for the early diagnosis of hepatocellular carcinoma.

  2015cited by this paper
• Metabolomics and its potential in drug development.

  2013cited by this paper
• Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.

  2013cited by this paper
• Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis.

  2012cited by this paper
• Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.

  2012cited by this paper
• Metabolomic markers for intestinal ischemia in a mouse model.

  2012cited by this paper
• Regulation of glucose metabolism in T cells: new insight into the role of Phosphoinositide 3-kinases

  2012cited by this paper
• Molecular and Cellular Pathobiology Wnt / Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism

  2012cited by this paper
• Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

  2012cited by this paper
• Hepatocellular carcinoma

  2012cited by this paper
• Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry.

  2012cited by this paper
• Multiple Metabolic Alterations Exist in Mutant PI3K Cancers, but Only Glucose Is Essential as a Nutrient Source

  2012cited by this paper
• Stat3‐mediated activation of microRNA‐23a suppresses gluconeogenesis in hepatocellular carcinoma by down‐regulating Glucose‐6‐phosphatase and peroxisome proliferator‐activated receptor gamma, coactivator 1 alpha

  2012cited by this paper
• Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma.

  2012cited by this paper
• LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.

  2012cited by this paper
• Biomarkers for early diagnosis of hepatocellular carcinoma.

  2012cited by this paper
• Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases

  2011cited by this paper
• Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.

  2011influential reference
• 1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis

  2011cited by this paper
• Early diagnosis of hepatocellular carcinoma by multiple microRNAs: validity, efficacy, and cost-effectiveness.

  2011cited by this paper
• Regulation of cancer cell metabolism

  2011cited by this paper
• Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method

  2011cited by this paper
• In vivo MRSI of hyperpolarized [1‐13C]pyruvate metabolism in rat hepatocellular carcinoma

  2011influential reference
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• Hepatocellular carcinoma associated lipid metabolism reprogramming.

  2011influential reference
• The production and composition of rat sebum is unaffected by 3 Gy gamma radiation

  2011cited by this paper
• Metabolomics Study of Stepwise Hepatocarcinogenesis From the Model Rats to Patients: Potential Biomarkers Effective for Small Hepatocellular Carcinoma Diagnosis*

  2011cited by this paper
• Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma*

  2011cited by this paper
• Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice.

  2011cited by this paper
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis.

  2010cited by this paper
• Surveillance and early diagnosis of hepatocellular carcinoma.

  2010cited by this paper
• Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors.

  2010cited by this paper
• Proteomic analysis of β‐catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway

  2009cited by this paper
• Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

  2009cited by this paper
• Radiation Metabolomics. 3. Biomarker Discovery in the Urine of Gamma-Irradiated Rats Using a Simplified Metabolomics Protocol of Gas Chromatography-Mass Spectrometry Combined with Random Forests Machine Learning Algorithm

  2009cited by this paper
• A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry.

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.

  2009cited by this paper
• Molecular background of α‐fetoprotein in liver cancer cells as revealed by global RNA expression analysis

  2008cited by this paper
• Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

  2007influential reference
• Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis.

  2007cited by this paper
• The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

  2006cited by this paper
• Cyclooxygenase-2 in hepatocellular carcinoma.

  2006cited by this paper
• Why do cancers have high aerobic glycolysis?

  2004cited by this paper
• Visualizing metabolic changes in breast‐cancer tissue using 1H‐NMR spectroscopy and self‐organizing maps

  2003cited by this paper
• Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis.

  2001cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper
• Principles of Biochemistry

  1984cited by this paper
• The oxidative desaturation of unsaturated fatty acids in animals

  1974cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Targeted lipidomics meets transcriptomics: how cinobufagin rewires fatty acid, sphingolipid, and glycerophospholipid metabolism to combat hepatoma cell growth.

  2026cites this paper
• Amniotic Membrane-Derived Extracellular Matrix for Developing a Cost-Effective Xenofree Hepatocellular Carcinoma Organoid Model.

  2025cites this paper
• Zonation, Zonation, Zonation: The Real Estate of the Liver.

  2025cites this paper
• Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer

  2025cites this paper
• Impact of mtG3PDH inhibitors on proliferation and metabolism of androgen receptor-negative prostate cancer cells: Role of extracellular pyruvate

  2025cites this paper
• Hierarchical structural component model for pathway analysis of multinomial phenotypes

  2025cites this paper
• Mitochondrial-Based Nanomedicine in Treatment of Liver Cancer.

  2025cites this paper
• Ferroptosis and the cGAS-STING pathway into precision nano-immuno-theranostics: A mechanistic paradigm for reversing drug resistance in hepatocellular carcinoma.

  2025cites this paper
• Metabolic adaptations in cancer progression.

  2025cites this paper
• Genetic Variants of UGP2 and FBP2 in the Glycolysis Pathway Independently Predict Survival of Patients with HBV-Related Hepatocellular Carcinoma

  2025influential citation
• Beyond borders: engineering organ-targeted immunotherapies to overcome site-specific barriers in cancer

  2025cites this paper
• Lipids: Driving Forces in the Underlying Biology of Carcinogenesis.

  2025cites this paper
• Nuclear magnetic resonance-based lipid metabolite profiles for differentiation of patients with liver cirrhosis with and without hepatocellular carcinoma

  2025influential citation
• Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications

  2025cites this paper
• Comprehensive molecular characteristics of hepatocellular carcinoma based on multi-omics analysis

  2025cites this paper
• Glycerol kinase enzyme is a prognostic predictor in esophageal carcinoma and is associated with immune cell infiltration

  2024cites this paper
• Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases

  2024cites this paper
• HBV DNA polymerase regulates tumor cell glycogen to enhance the malignancy of HCC cells

  2024cites this paper
• Lactic acid: The culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma.

  2024cites this paper
• RABIF promotes hepatocellular carcinoma progression through regulation of mitophagy and glycolysis

  2024cites this paper
• In Vivo Time‐Resolved Fluorescence Detection of Liver Cancer Supported by Machine Learning

  2024cites this paper
• Evolution and applications of Next Generation Sequencing and its intricate relations with chromatographic and spectrometric techniques in modern day sciences

  2024cites this paper
• Generalizable transcriptome-based tumor malignant level evaluation and molecular subtyping towards precision oncology

  2024cites this paper
• NAT1 inhibits liver metastasis of colorectal cancer by regulating EMT and glycolysis

  2024cites this paper
• Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma.

  2024cites this paper
• Exosomal SLC16A1-AS1-induced M2 macrophages polarization facilitates hepatocellular carcinoma progression

  2024cites this paper
• Downregulation of Brf1 Induces Liver Failure and Inhibits Hepatocellular Carcinoma Progression by Promoting Apoptosis

  2024cites this paper
• The Metabolomic Footprint of Liver Fibrosis

  2024cites this paper
• Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review)

  2024cites this paper
• A proton birdcage coil integrated with interchangeable single loops for multi-nuclear MRI/MRS

  2024cites this paper
• Specific features of ß-catenin-mutated hepatocellular carcinomas

  2024cites this paper
• Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• New metabolic insights into the mechanism of ifosfamide encephalopathy.

  2024cites this paper
• Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2

  2023cites this paper
• Arachidonic acid metabolism CYP450 pathway is deregulated in hepatocellular carcinoma and associated with microvascular invasion

  2023cites this paper
• Hilpda, A New Player In Nash-Driven Hcc, Links Hypoxia Signaling With Ceramide Synthesis.

  2023cites this paper
• The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions

  2023cites this paper
• Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis

  2023cites this paper
• Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches

  2023cites this paper
• Machine learning facilitates the application of mass spectrometry-based metabolomics to clinical analysis: A review of early diagnosis of high mortality rate cancers

  2023cites this paper
• Development of Prognostic Features of Hepatocellular Carcinoma Based on Metabolic Gene Classification and Immune and Oxidative Stress Characteristic Analysis

  2023cites this paper
• Comprehensive spectroscopic, metabolomic, and proteomic liquid biopsy in the diagnostics of hepatocellular carcinoma.

  2023cites this paper
• Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine

  2023cites this paper
• Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review.

  2023cites this paper
• PC 18:1/18:1 mediates the anti-inflammatory effects of exercise and remodels tumor microenvironment of hepatocellular carcinoma.

  2023cites this paper
• Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through Akt and c-Src signaling pathways

  2023cites this paper
• Hepatitis C Virus Infection Upregulates Plasma Phosphosphingolipids and Endocannabinoids and Downregulates Lysophosphoinositols

  2023cites this paper
• Real-time monitoring of glucose metabolism and effects of metformin on HepG2 cells using 13C in-cell NMR spectroscopy.

  2023cites this paper
• 1H-NMR-based metabolomics reveals the biomarker panel and molecular mechanism of hepatocellular carcinoma progression

  2022cites this paper
• Bioinformatics analysis and experimental verification of five metabolism-related lncRNAs as prognostic models for hepatocellular carcinoma

  2022cites this paper
• Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis

  2022cites this paper
• The metabolomics of a protein kinase C delta (PKCδ) knock-out mouse model

  2022cites this paper
• Proton-coupled monocarboxylate transporters in cancer: From metabolic crosstalk, immunosuppression and anti-apoptosis to clinical applications

  2022cites this paper
• A Metabolomic Analysis of Cirrhotic Ascites

  2022cites this paper
• PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition

  2022cites this paper
• Addition of grapes to both a standard and a high-fat Western pattern diet modifies hepatic and urinary metabolite profiles in the mouse.

  2022cites this paper
• Optimised systematic review tool: Application to candidate biomarkers for the diagnosis of hepatocellular carcinoma.

  2022cites this paper
• Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells

  2022cites this paper
• The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression

  2022cites this paper
• TSP50 promotes the Warburg effect and hepatocyte proliferation via regulating PKM2 acetylation

  2021cites this paper
• The Biochemical investigation and analysis to determine a potent biomarker for HCC and HCV infections

  2021cites this paper
• UPLC-MS-Based Serum Metabolomics Reveals Potential Biomarkers of Ang II-Induced Hypertension in Mice

  2021cites this paper
• NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial

  2021cites this paper
• Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells

  2021cites this paper
• Inducible Liver Cancer Models in Transgenic Zebrafish to Investigate Cancer Biology

  2021cites this paper
• Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation.

  2021cites this paper
• B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis

  2021cites this paper
• Liver: glucose metabolism and 18F-fluorodeoxyglucose PET findings in normal parenchyma and diseases.

  2021cites this paper
• Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis Severity

  2021cites this paper
• Ras related GTP binding D promotes aerobic glycolysis of hepatocellular carcinoma.

  2021cites this paper
• Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks

  2021cites this paper
• New insights into the anti- hepatoma mechanism of triple-helix β- glucan by metabolomics profiling.

  2021cites this paper
• Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures.

  2021cites this paper
• Metabolic Rewiring and the Characterization of Oncometabolites

  2021cites this paper
• Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma

  2021cites this paper
• Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver Carcinogenesis

  2021cites this paper
• Down-regulation of a Mitochondrial Micropeptide MPM Promotes Hepatoma Metastasis by Enhancing Mitochondrial Complex I Activity.

  2021cites this paper
• Analysis of Key Genes Regulating the Warburg Effect in Patients with Gastrointestinal Cancers and Selective Inhibition of This Metabolic Pathway in Liver Cancer Cells

  2020cites this paper
• Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect

  2020cites this paper
• A New Workflow for the Analysis of Phosphosite Occupancy in Paired Samples by Integration of Proteomics and Phosphoproteomics Data Sets.

  2020cites this paper
• Prognostic value of a metastasis-related gene signature in hepatocellular carcinoma

  2020cites this paper
• Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma

  2020cites this paper
• Reduction of Polyunsaturated Fatty Acids with Tumor Progression in a Lean Non-Alcoholic Steatohepatitis-Associated Hepatocellular Carcinoma Mouse Model

  2020cites this paper
• Lipid metabolism in cancer progression and therapeutic strategies

  2020cites this paper
• Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues

  2020cites this paper
• The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer

  2020cites this paper
• Novel mitochondrion‐targeting copper(II) complex induces HK2 malfunction and inhibits glycolysis via Drp1‐mediating mitophagy in HCC

  2020cites this paper
• 1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages

  2020cites this paper
• Combined DCE-MRI- and FDG-PET enable histopathological grading prediction in a rat model of hepatocellular carcinoma.

  2020cites this paper
• Hepatic glycerol metabolism is early reprogrammed in rat liver cancer development.

  2020cites this paper
• DDX23 is a Metabolic Regulator in Hepatocellular Carcinoma

  2020cites this paper
• CMAR_A_258196 5957..5974

  2020cites this paper
• Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma

  2020cites this paper
• PPARγ Coactivator‐1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ–Dependent WNT/β‐Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis

  2020cites this paper
• Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma

  2020cites this paper
• Maternal plasma miRNAs as potential biomarkers for detecting risk of small-for-gestational-age births

  2020cites this paper
• Endurance training but not high-intensity interval training reduces liver carcinogenesis in mice with hepatocellular carcinogen diethylnitrosamine.

  2020cites this paper
• Targeting lipid metabolism in liver cancer.

  2020cites this paper
• Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients

  2020cites this paper
• OTT_A_257944 7295..7304

  2020cites this paper